Camden and Campbelltown Hospitals are New South Wales public hospitals servicing the Macarthur region. Camden and Campbelltown hospitals operate under a single common executive management structure, with services delivered across both hospitals.

There are 306 beds in Campbelltown Hospital.

During the past decade, Campbelltown Hospital conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 4 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Campbelltown Hospital" #1 sponsor was "Trans Tasman Radiation Oncology Group" with 3 trials, followed by "University of Sydney" with 3 trials sponsored, "Australasian Gastro-Intestinal Trials Group" with 2 trials sponsored, "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 2 trials sponsored and "Canadian Cancer Trials Group" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Campbelltown Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 4 trials as a collaborator, "Cancer Trials Ireland" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 2 trials as a collaborator and "Bayer" with 2 trials as a collaborator. Other collaborators include 67 different institutions and companies that were collaborators in the rest 74 trials.

According to Clinical.Site data, the most researched conditions in "Campbelltown Hospital" are "Breast Cancer" (2 trials), "Chromophobe Renal Cell Carcinoma" (2 trials), "Hereditary Angioedema (HAE)" (2 trials), "Papillary Renal Cell Carcinoma Type 1" (2 trials) and "Papillary Renal Cell Carcinoma Type 2" (2 trials). Many other conditions were trialed in "Campbelltown Hospital" in a lesser frequency.

Most popular intervention types in "Campbelltown Hospital" are "Drug" (25 trials), "Radiation" (5 trials), "Biological" (4 trials), "Procedure" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Nivolumab" (3 trials), "Docetaxel" (2 trials), "ARB + DMX-200" (1 trials) and "Amoxicillin-clavulanate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Campbelltown Hospital" are 23 trials for "All" genders, 4 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Campbelltown Hospital". undefined are not yet recruiting, 10 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Campbelltown Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Campbelltown Hospital, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".